CME on Gynae Oncopathology 2022 is being organized around the theme “Diagnosing and treating Gynaecological cancers – The way forward” by the department of Laboratory services along with the British Association of Gynaecological Pathologists (BAGP). The emphasis will be on approach to diagnosis, treatment modalities and molecular insights into various gynaecological malignancies.
This multimodality CME will have sessions related to diagnostic updates, WHO classification and case discussions addressing the current issues in Pathology, Surgery, Medical and Radiation Oncology. The CME is one stop destination for practicing pathologists and oncologists with keen interest in gynae-oncology. This will equally benefit the young practising pathologists, medical oncologists and surgeons planning to choose gynae-oncology in their future.
Consultant Histopathologist, Birmingham Women’s Hospital
University of Virginia, U.K
Lead Gynaepathologist at University College London Hospital
U.K
Lead Gynaecological Pathologist for the Northern Gynaecological Oncology Centre
U.K
Consultant Histopathologist and an international expert on trophoblastic diseases and malignant ovarian Germ cell tumours
U.KRGCIRC in collaboration with BAGP
9th July, 2022
Registration
Dr. Rupinder Sekhon
Gynae OncoSurgeon, Delhi
Welcome
| Dr Gurudutt Gupta Histopathologist, Delhi |
WHO Female Genital Tumours 5th edition-Overview
Dr Meenakshi Kamboj
Histopathologist, Delhi
Staging of Female Genital Tract Malignancies
Dr Hema Malini Aiyer
Histopathologist, Delhi
Challenges in diagnosing Endometrial Carcinoma on Curettings/Biopsy
Dr Rupinder Sekhon
Gynae OncoSurgeon, Delhi
Surgical Implications of Pre-operative diagnosis in Carcinoma Endometrium
Dr Vineet Talwar
Medical Oncologist, Delhi
Role of Chemotherapy in Carcinoma Endometrium
| Dr D.S. Negi |
CEO, RGCIRC
Dr Sudhir Rawal
Medical Director & Chief of GenitoUro-Oncology Services, RGCIRC
Dr Anurag Mehta
Director Dept of Laboratory & Transfusion Services and Director Research, RGCIRC
Inauguration
TEA
Dr Angela Ralte
Gynaecological Pathologist, North East and Yorkshire Cervical Screening Centre
Molecular Classification of Endometrial Cancers and MMR-IHC Interpretation
Dr Raji Ganesan
Histopathologist and President of BAGP, London
Endometrial Stromal Sarcoma- New Molecular Categories
Dr Baljeet Kaur
Histopathologist, London
Trophoblastic Neoplasms: When is it not just Products of Conception (Molar Pregnancy, PSTT,ETT)
LUNCH
| Dr Sunil Pasricha Histopathologist, Delhi |
Precursor lesions in cervical tumors
Dr Rupali Arora
Gynaecological Pathologist and BAGP co-meeting secretary, London
WHO Classification of Cervical Adenocarcinomas ( including relevance of Silva pattern of invasion)
| Dr Kedar K Deodhar Histopathologist, Mumbai |
Borderline Tumors of Ovary, Challenges in frozen section reporting
| Dr Ullas Batra Medical Oncologist, Delhi |
Role of Chemotherapy in Ovarian Malignancies
| Dr Santosh Menon Histopathologist, Mumbai |
| Ovarian Sex Cord Stromal Tumors |
Dr Anila Sharma
Histopathologist, Delhi
| Woes of a Gynaec-Pathologist |
Dr Vandana Jain
Gynaec- Oncosurgeon, Delhi
| Staging and Surgical Approach of Cervical Malignancies |
Dr Swarupa Mitra
Radiation Oncologist, Delhi
| Radiotherapy in Adenoarcinoma Cervix – Is it time to change protocol? |
Dr. Gurudutt Gupta/ Dr. Anila Sharma
Histopathologist, Delhi
| Case Discussion |
DMC Speaker
| Lecture on Ethical Issues (6 cases) |
Dr Anila Sharma
Histopathologist, Delhi
| Vote of Thanks & Valedictory function |
Abstract Submission for e-posters – Last date 1st June (before 10 AM)
Abstract should be of maximum 300 words (PDF Format) unstructured paragraph covering: Background, Material + Methods, Results and Conclusion.
The theme should be related to Gynaec-oncology/pathology.
5 ppt slides (16:9) for poster covering: Title, Authors & Institute, Material & Methods, Results, Conclusions &Reference.
Only 20 e-posters will be selected & displayed on the day of the CME.
Please send your abstract to mail id drmeenakshikamboj@gmail.com.
In case of any clarification needed, please whatsApp at mobile no. +91 9891926536.
Abstract Submission for case presentation – Last date 1st June (before 10 AM)
Abstract should be of maximum 200 words (PDF Format) unstructured paragraph covering: History, Histopath findings, IHC,/Molecular Testing and discussion.
The theme should be related to Gynaec-oncology/pathology.
The selected case will be an oral presentation by a Consultant for duration of 10 min (9mins presentation + 1min Discussion).
Only 6 cases will be selected depending on the detailed workup and clinical relevance.
Please send your abstract to mail id dranila_sharma@yahoo.com
In case of any clarification needed, please whatsApp at mobile no. +91 9810956375.
Sr. Consultant – Dept. of Histopathology
RGCIRC, Delhi Email: sharma.anila@rgcirc.org +91 9810956375
Consultant- Dept. of Histopathology
RGCIRC, Delhi Email: kamboj.meenakshi@rgcirc.org +91 9891926536
Conference Co-ordinator
RGCIRC, Delhi Email: bohara.pinky@rgcirc.org +91 9311291311
As a society, RGCIRC is looking forward to get support from generous people
Read More
It is a fact that there are absolutely no substitutes to replace human bloo...
Read More
Volunteers play an important role in today’s hospitals. They help the hos...
Read MoreRajiv Gandhi Cancer Institute and Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.
Sir Chotu Ram Marg, Sector - 5, Rohini Industrial Area, Rohini, New Delhi - 110085, India | +91-11-47022222 OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday) Emergency Services: 24x7 All weekdays
Squadron Leader Mahendra Kumar Jain Marg, Block K, Niti Bagh, New Delhi - 110049 | +91-11-45822222 OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday) Emergency Services: 24x7 All Weekdays
